See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Aug. 30, 2006

Vaccines Peripheral Arterial Occlusive Disease Fibromyalgia

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:


This study will examine the safety and effectiveness of a meningitis vaccine (Menactra) when given at the same time as the standard diphtheria, tetanus, pertussis vaccine (Daptacel) in children 4-6 years old. Your child may be eligible for the study if your child is healthy and has no history of serious medical problems and has not yet received his/her fifth booster dose of diphtheria, tetanus, pertussis vaccine.

Research sites are located throughout the United States.

More information

Please see


Peripheral Arterial Occlusive Disease

This study will evaluate the safety and effectiveness of the study drug intra-thrombus alfimeprase 0.3mg/kg compared with a non-medicinal placebo in people with acute peripheral arterial occlusion (PAO). Volunteers must be 18 or older with arteriographically-confirmed acute PAO of the lower extremity with onset of symptoms within 14 days, must not have a history of significant acute or chronic kidney disease that would preclude contrast angiography, and must not have a known allergy to contrast agents.

The research site is in Little Rock, Ark.

More information

Please see



If you have pain associated with fibromyalgia, you may be eligible for this research study of an investigational medication. Qualified candidates 18-70 will receive study-related examinations, lab work, and study medication at no cost, and may be eligible for travel expense compensation.

The research site is in Columbus, Ohio.

More information

Please see


Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.